641 related articles for article (PubMed ID: 6683558)
1. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
Hutt V; Wechsler JG; Klör HU; Ditschuneit H
Arzneimittelforschung; 1983; 33(5):776-9. PubMed ID: 6683558
[TBL] [Abstract][Full Text] [Related]
2. Changes in the concentration and composition of lipids and lipoproteins in primary hyperlipoproteinemia during treatment with bezafibrate.
Hutt V; Wechsler JG; Klör HU; Ditschuneit H
Arzneimittelforschung; 1983; 33(8):1185-90. PubMed ID: 6685498
[TBL] [Abstract][Full Text] [Related]
3. [Effect of beta-pyridylcarbinol on lipids and lipoprotein in primary type IIa hyperlipoproteinemia].
Hutt V; Wechsler JG; Klör HU; Ditschuneit H
Arzneimittelforschung; 1983; 33(12):1682-4. PubMed ID: 6686774
[TBL] [Abstract][Full Text] [Related]
4. [Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV, and V hyperlipemia patients in comparison with healthy individuals].
Hutt V; Klör HU; Wechsler JG; Ditschuneit H
J Clin Chem Clin Biochem; 1984 Feb; 22(2):141-6. PubMed ID: 6716054
[TBL] [Abstract][Full Text] [Related]
5. Changes in lipids and lipoproteins in patients with hyperlipidemia type IIb, IV and V treated with different lipid lowering drugs.
Hutt V; Wechsler JG; Klör HU; Ditschuneit H
Artery; 1980; 8(2):113-9. PubMed ID: 7458676
[TBL] [Abstract][Full Text] [Related]
6. Effects of oxandrolone on plasma lipoproteins in patients with type IIa, IIb and IV hyperlipoproteinemia: occurrence of hypo-high density lipoproteinemia.
Tamai T; Nakai T; Yamada S; Kobayashi T; Hayashi T; Kutsumi Y; Takeda R
Artery; 1979 Feb; 5(2):125-43. PubMed ID: 231951
[TBL] [Abstract][Full Text] [Related]
7. Lipids and lipoproteins in hyperlipidemia type IIa during treatment with different lipid lowering drugs.
Wechsler JG; Hutt V; Klör HU; Ditschuneit H
Artery; 1980; 8(6):519-29. PubMed ID: 7259531
[TBL] [Abstract][Full Text] [Related]
8. Lowering effect of fenofibrate (procetofene) on lipoproteins in different types of hyperlipoproteinemias.
Canzler H; Bojanovski D
Artery; 1980; 8(2):171-8. PubMed ID: 7458684
[TBL] [Abstract][Full Text] [Related]
9. [Combination or monotherapy of hyperlipoproteinemia typus IIb, IV, V with clofibrate and m-inositolnicotinate or clofibrinic acid (author's transl)].
Schwartzkopff W; Zschiedrich M
Med Klin; 1978 Feb; 73(7):231-9. PubMed ID: 203832
[TBL] [Abstract][Full Text] [Related]
10. [On the effect of etofylline clofibrate on serum lipids and lipoproteins in patients with hyperlipoproteinemia of various degrees (author's transl)].
Schneider J; Mühlfellner G; Mühlfellner O; Hausmann L; Schubotz R
Arzneimittelforschung; 1980; 30(11b):2059-62. PubMed ID: 7194060
[TBL] [Abstract][Full Text] [Related]
11. [The problem of type changes in hyperlipoproteinemia (type IIb, IV, V) under clofibrate and m-inositol nicotinate therapy].
Schwartzkopff W; Zschiedrich M
Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():825-9. PubMed ID: 196436
[No Abstract] [Full Text] [Related]
12. Effects of nicotinic acid therapy on plasma lipoproteins and very low density lipoprotein apoprotein C subspecies in hyperlipoproteinemia.
Yovos JG; Patel ST; Falko JM; Newman HA; Hill DS
J Clin Endocrinol Metab; 1982 Jun; 54(6):1210-5. PubMed ID: 7076797
[TBL] [Abstract][Full Text] [Related]
13. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types].
Noseda G; Fragiacomo C; Weidmann P; Bachmann C
Schweiz Med Wochenschr; 1980 Dec; 110(49):1875-7. PubMed ID: 7455660
[TBL] [Abstract][Full Text] [Related]
14. Plasma lipoprotein levels and the prevalence of hyperlipoproteinemia in a Canadian working population.
Jones GJ; Hewitt D; Godin GJ; Breckenridge WC; Bird J; Mishkel MA; Steiner G; Little JA
Can Med Assoc J; 1980 Jan; 122(1):37-8, 40-6. PubMed ID: 7363194
[TBL] [Abstract][Full Text] [Related]
15. [Effect of omega-3-fatty acids on lipoprotein metabolism. Different effects in various phenotypes].
Singer P; Hüve J
Fortschr Med; 1991 Aug; 109(24):476-9. PubMed ID: 1937329
[TBL] [Abstract][Full Text] [Related]
16. Serum lipoprotein lipids after gemfibrozil treatment.
Schwandt P; Weisweiler P; Neureuther G
Artery; 1979 Feb; 5(2):117-24. PubMed ID: 231950
[TBL] [Abstract][Full Text] [Related]
17. Studies on the phenotyping system of hyperlipoproteinemias. Evaluation of a new method by enzymic staining of lipids in serum lipoproteins separated by electrophoresis on agarose.
Ohno F; Suehiro T; Uga S; Kawada M; Takamatsu K; Yasuoka N; Yamano T
Jpn J Med; 1983 Aug; 22(3):200-5. PubMed ID: 6620708
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of hyperlipoproteinaemia types IIa, IIb, IV and V with a combination of clofibrate and inositol nicotinate (author's transl)].
Wilke H; Frahm H
Dtsch Med Wochenschr; 1976 Mar; 101(11):401-5. PubMed ID: 1253701
[TBL] [Abstract][Full Text] [Related]
19. [Effect of etofylline clofibrate on the composition of lipoproteins in hyperlipidaemia type IIb and IV (author's transl)].
Ditschuneit HH; Hutt V; Klör HU; Ditschuneit H
Arzneimittelforschung; 1980; 30(11b):2063-7. PubMed ID: 7194061
[TBL] [Abstract][Full Text] [Related]
20. Changes in serum and lipoprotein lipids, and apolipoprotein B and A-I, in patients with different types of primary hyperlipoproteinaemia treated with gemfibrozil.
Sommariva D; Branchi A; Pini C; Scandiani L; Orlandi S; Fasoli A
Int J Clin Pharmacol Res; 1988; 8(5):383-92. PubMed ID: 3068163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]